Mohammadi Irdemousa, M., Mahmoodzadeh Hosseini, H., Sotoodehnejadnematalahi, F. & Mirhosseini, S. A. (2026). Design and Synthesis of Immunotoxin Consisting of Blinatumomab Antibody (Anti-CD19) and Burkholderia Lethal Factor 1 (BLF1) Investigating in Vitro Effect on NALM6 Cell Line in B-All Cancer. (e742850). Iranian Biomedical Journal, (), e742850

Mohammadi Irdemousa, M., Mahmoodzadeh Hosseini, H., Sotoodehnejadnematalahi, F., & Mirhosseini, S. A. "Design and Synthesis of Immunotoxin Consisting of Blinatumomab Antibody (Anti-CD19) and Burkholderia Lethal Factor 1 (BLF1) Investigating in Vitro Effect on NALM6 Cell Line in B-All Cancer" .e742850 , Iranian Biomedical Journal, , 2026, e742850.

Mohammadi Irdemousa M., Mahmoodzadeh Hosseini H., Sotoodehnejadnematalahi F., Mirhosseini S. A. (2026). 'Design and Synthesis of Immunotoxin Consisting of Blinatumomab Antibody (Anti-CD19) and Burkholderia Lethal Factor 1 (BLF1) Investigating in Vitro Effect on NALM6 Cell Line in B-All Cancer', Iranian Biomedical Journal, (), e742850.

M. Mohammadi Irdemousa, H. Mahmoodzadeh Hosseini, F. Sotoodehnejadnematalahi & S. A. Mirhosseini, "Design and Synthesis of Immunotoxin Consisting of Blinatumomab Antibody (Anti-CD19) and Burkholderia Lethal Factor 1 (BLF1) Investigating in Vitro Effect on NALM6 Cell Line in B-All Cancer," Iranian Biomedical Journal, (2026): e742850,

Mohammadi Irdemousa M., Mahmoodzadeh Hosseini H., Sotoodehnejadnematalahi F., Mirhosseini S. A. Design and Synthesis of Immunotoxin Consisting of Blinatumomab Antibody (Anti-CD19) and Burkholderia Lethal Factor 1 (BLF1) Investigating in Vitro Effect on NALM6 Cell Line in B-All Cancer. Iranian Biomedical Journal. 2026;():e742850.